The new analysis, presented at ESC Congress 2022, found that a medical marijuana prescription for chronic pain may increase a person's overall arrhythmia risk. 

The new analysis, based on data from more than 330,000 patients, is scheduled to be presented during ESC Congress 2022. 

To avoid a potential shortage, FDA officials have said the medications can be sold to patients on a temporary basis. 

New research out of the Yale School of Public Health suggests that patients taking beta-blockers or antiplatelet medications may want to be extra careful in warmer weather.

After successfully making it through the House, the new legislation is now headed to the Senate.